The European Medicines Agency's (EMA) safety committee has concluded that a potentially dangerous eye condition is a very ...

Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...

The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

An Ozempic warning has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for any women taking ...

During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

QSRs, retailers and airlines fuel ad activity across Canada, according to the latest AdEase data for the week of May 26 to ...

A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...